Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells

Yutaka Kawakami, S. Hama, M. Hiura, T. Nogawa, T. Chiba, T. Yokoyama, S. Takashima, H. Tajiri, K. Eguchi, N. Nagai, K. Shigemasa, K. Ohama, K. Kurisu, Y. Heike

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Deletions and point mutations of the p16 gene are detectable in more than 50% of ovarian cancer cells. In this study, we examined the effect of p16 gene transduction on the growth of ovarian cancer cells and on the effect of anti-cancer agents. Materials and Methods: p16-null human ovarian cancer cell lines, SKOV-3 and OVCAR-5, were used in this study. We transduced the full-length human p16 gene using recombinant adenovirus (AxCA-hp16). Results: The spontaneous growth of these cells was significantly inhibited by hp16 transduction. MTT assay revealed that AxCA-hp16 infection induced chemoresistance in both cell lines. Flow cytometric analysis revealed that only hp16-transduced SKOV-3, were arrested at the G1-phase for 3 days whereas those infected with AxCA-mock and OVCAR-5 infected with both recombinant viruses did not. Western blot analysis showed increased microtubule-associated proteins 4 (MAP4) in both cell lines. Conclusion: These results suggest that in SKOV-3 cells, G1-arrest induced by p16-transduction prevents paclitaxel- and vindesine- induced cell death, and in OVCAR-5 cells, the other unknown mechanisms play a role of chemoresistance.

Original languageEnglish
Pages (from-to)2537-2546
Number of pages10
JournalAnticancer Research
Volume21
Issue number4 A
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Vinca Alkaloids
p16 Genes
Taxoids
Adenoviridae
Ovarian Neoplasms
Cell Line
Vindesine
Sequence Deletion
G1 Phase
Growth
Paclitaxel
Point Mutation
Cell Death
Western Blotting
Viruses
Infection
Neoplasms

Keywords

  • Chemoresistance
  • Growth inhibition
  • MAP4
  • Ovarian cancer
  • P16

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kawakami, Y., Hama, S., Hiura, M., Nogawa, T., Chiba, T., Yokoyama, T., ... Heike, Y. (2001). Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells. Anticancer Research, 21(4 A), 2537-2546.

Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells. / Kawakami, Yutaka; Hama, S.; Hiura, M.; Nogawa, T.; Chiba, T.; Yokoyama, T.; Takashima, S.; Tajiri, H.; Eguchi, K.; Nagai, N.; Shigemasa, K.; Ohama, K.; Kurisu, K.; Heike, Y.

In: Anticancer Research, Vol. 21, No. 4 A, 2001, p. 2537-2546.

Research output: Contribution to journalArticle

Kawakami, Y, Hama, S, Hiura, M, Nogawa, T, Chiba, T, Yokoyama, T, Takashima, S, Tajiri, H, Eguchi, K, Nagai, N, Shigemasa, K, Ohama, K, Kurisu, K & Heike, Y 2001, 'Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells', Anticancer Research, vol. 21, no. 4 A, pp. 2537-2546.
Kawakami, Yutaka ; Hama, S. ; Hiura, M. ; Nogawa, T. ; Chiba, T. ; Yokoyama, T. ; Takashima, S. ; Tajiri, H. ; Eguchi, K. ; Nagai, N. ; Shigemasa, K. ; Ohama, K. ; Kurisu, K. ; Heike, Y. / Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells. In: Anticancer Research. 2001 ; Vol. 21, No. 4 A. pp. 2537-2546.
@article{976af91bc3a240d0936d257cb19b53ad,
title = "Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells",
abstract = "Background: Deletions and point mutations of the p16 gene are detectable in more than 50{\%} of ovarian cancer cells. In this study, we examined the effect of p16 gene transduction on the growth of ovarian cancer cells and on the effect of anti-cancer agents. Materials and Methods: p16-null human ovarian cancer cell lines, SKOV-3 and OVCAR-5, were used in this study. We transduced the full-length human p16 gene using recombinant adenovirus (AxCA-hp16). Results: The spontaneous growth of these cells was significantly inhibited by hp16 transduction. MTT assay revealed that AxCA-hp16 infection induced chemoresistance in both cell lines. Flow cytometric analysis revealed that only hp16-transduced SKOV-3, were arrested at the G1-phase for 3 days whereas those infected with AxCA-mock and OVCAR-5 infected with both recombinant viruses did not. Western blot analysis showed increased microtubule-associated proteins 4 (MAP4) in both cell lines. Conclusion: These results suggest that in SKOV-3 cells, G1-arrest induced by p16-transduction prevents paclitaxel- and vindesine- induced cell death, and in OVCAR-5 cells, the other unknown mechanisms play a role of chemoresistance.",
keywords = "Chemoresistance, Growth inhibition, MAP4, Ovarian cancer, P16",
author = "Yutaka Kawakami and S. Hama and M. Hiura and T. Nogawa and T. Chiba and T. Yokoyama and S. Takashima and H. Tajiri and K. Eguchi and N. Nagai and K. Shigemasa and K. Ohama and K. Kurisu and Y. Heike",
year = "2001",
language = "English",
volume = "21",
pages = "2537--2546",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 A",

}

TY - JOUR

T1 - Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells

AU - Kawakami, Yutaka

AU - Hama, S.

AU - Hiura, M.

AU - Nogawa, T.

AU - Chiba, T.

AU - Yokoyama, T.

AU - Takashima, S.

AU - Tajiri, H.

AU - Eguchi, K.

AU - Nagai, N.

AU - Shigemasa, K.

AU - Ohama, K.

AU - Kurisu, K.

AU - Heike, Y.

PY - 2001

Y1 - 2001

N2 - Background: Deletions and point mutations of the p16 gene are detectable in more than 50% of ovarian cancer cells. In this study, we examined the effect of p16 gene transduction on the growth of ovarian cancer cells and on the effect of anti-cancer agents. Materials and Methods: p16-null human ovarian cancer cell lines, SKOV-3 and OVCAR-5, were used in this study. We transduced the full-length human p16 gene using recombinant adenovirus (AxCA-hp16). Results: The spontaneous growth of these cells was significantly inhibited by hp16 transduction. MTT assay revealed that AxCA-hp16 infection induced chemoresistance in both cell lines. Flow cytometric analysis revealed that only hp16-transduced SKOV-3, were arrested at the G1-phase for 3 days whereas those infected with AxCA-mock and OVCAR-5 infected with both recombinant viruses did not. Western blot analysis showed increased microtubule-associated proteins 4 (MAP4) in both cell lines. Conclusion: These results suggest that in SKOV-3 cells, G1-arrest induced by p16-transduction prevents paclitaxel- and vindesine- induced cell death, and in OVCAR-5 cells, the other unknown mechanisms play a role of chemoresistance.

AB - Background: Deletions and point mutations of the p16 gene are detectable in more than 50% of ovarian cancer cells. In this study, we examined the effect of p16 gene transduction on the growth of ovarian cancer cells and on the effect of anti-cancer agents. Materials and Methods: p16-null human ovarian cancer cell lines, SKOV-3 and OVCAR-5, were used in this study. We transduced the full-length human p16 gene using recombinant adenovirus (AxCA-hp16). Results: The spontaneous growth of these cells was significantly inhibited by hp16 transduction. MTT assay revealed that AxCA-hp16 infection induced chemoresistance in both cell lines. Flow cytometric analysis revealed that only hp16-transduced SKOV-3, were arrested at the G1-phase for 3 days whereas those infected with AxCA-mock and OVCAR-5 infected with both recombinant viruses did not. Western blot analysis showed increased microtubule-associated proteins 4 (MAP4) in both cell lines. Conclusion: These results suggest that in SKOV-3 cells, G1-arrest induced by p16-transduction prevents paclitaxel- and vindesine- induced cell death, and in OVCAR-5 cells, the other unknown mechanisms play a role of chemoresistance.

KW - Chemoresistance

KW - Growth inhibition

KW - MAP4

KW - Ovarian cancer

KW - P16

UR - http://www.scopus.com/inward/record.url?scp=0035157892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035157892&partnerID=8YFLogxK

M3 - Article

C2 - 11724319

AN - SCOPUS:0035157892

VL - 21

SP - 2537

EP - 2546

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 A

ER -